OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12
Showing 12 citing articles:
Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 28
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 28
Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment
Nuo Cheng, Qianqian Zhou, Zongfang Jia, et al.
Materials Today Bio (2025) Vol. 30, pp. 101441-101441
Open Access | Times Cited: 1
Nuo Cheng, Qianqian Zhou, Zongfang Jia, et al.
Materials Today Bio (2025) Vol. 30, pp. 101441-101441
Open Access | Times Cited: 1
Circadian clock regulates immune checkpoint inhibitor efficacy
Yining Niu, Motao Zhu
Acta Pharmaceutica Sinica B (2025) Vol. 15, Iss. 2, pp. 1183-1185
Open Access
Yining Niu, Motao Zhu
Acta Pharmaceutica Sinica B (2025) Vol. 15, Iss. 2, pp. 1183-1185
Open Access
Role of liposomes in chemoimmunotherapy of Breast cancer
Fatemeh Attarian, Ghazaleh Hatamian, Shamim Nosrati, et al.
Journal of drug targeting (2025), pp. 1-43
Closed Access
Fatemeh Attarian, Ghazaleh Hatamian, Shamim Nosrati, et al.
Journal of drug targeting (2025), pp. 1-43
Closed Access
Recent advances in nano-molybdenum oxide for photothermal cancer therapy
S Chen, Ping Zhang, Hongmei Bai, et al.
Nanomedicine (2025), pp. 1-19
Closed Access
S Chen, Ping Zhang, Hongmei Bai, et al.
Nanomedicine (2025), pp. 1-19
Closed Access
Liposomes and Niosomes: New trends and applications in the delivery of bioactive agents for cancer therapy
Helena de Almeida Cerqueira Kodel, Paria Alizadeh, Samad Nejad Ebrahimi, et al.
International Journal of Pharmaceutics (2024), pp. 124994-124994
Closed Access | Times Cited: 4
Helena de Almeida Cerqueira Kodel, Paria Alizadeh, Samad Nejad Ebrahimi, et al.
International Journal of Pharmaceutics (2024), pp. 124994-124994
Closed Access | Times Cited: 4
Immunoregulatory role of exosomal circRNAs in the tumor microenvironment
Changsheng Lv, Jinhao Chen, Yuxiang Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Changsheng Lv, Jinhao Chen, Yuxiang Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy
Yuli Ge, Qiong Zhou, Fan Pan, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2371-2394
Open Access
Yuli Ge, Qiong Zhou, Fan Pan, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2371-2394
Open Access
Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy
Yuxin Zhang, Jie Zhou, Yiyan Wang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113606-113606
Closed Access
Yuxin Zhang, Jie Zhou, Yiyan Wang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113606-113606
Closed Access
Reversing cancer immunosuppression via K+ capture and repolarization of tumor-associated macrophages
Si‐Ye Tong, Cong‐Min Huo, Yu‐Cheng Zuo, et al.
Nanoscale Horizons (2025)
Closed Access
Si‐Ye Tong, Cong‐Min Huo, Yu‐Cheng Zuo, et al.
Nanoscale Horizons (2025)
Closed Access
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen, Dhanshree Vikrant Konde, Safal Kumar Paikray, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Suphiya Parveen, Dhanshree Vikrant Konde, Safal Kumar Paikray, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Remodeling tumor immunosuppressive microenvironment through dual activation of immunogenic panoptosis and ferroptosis by H2S-amplified nanoformulation to enhance cancer immunotherapy
Ying‐Li Luo, Maoyuan Linghu, Xianyu Luo, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access | Times Cited: 1
Ying‐Li Luo, Maoyuan Linghu, Xianyu Luo, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access | Times Cited: 1
Improving the Anti-Tumor Effect of Indoleamine 2,3-Dioxygenase Inhibitor CY1-4 by CY1-4 Nano-Skeleton Drug Delivery System
Hui Li, Jun-Wei Liu, Jingru Wang, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 12, pp. 372-372
Open Access
Hui Li, Jun-Wei Liu, Jingru Wang, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 12, pp. 372-372
Open Access
